New perspectives for gene therapy in endocrinology

L Barzon1, R Bonaguro, G Palù

  • 1Department of Medical and Surgical Sciences, University of Padova, Padova, Italy.

Insights

Gene therapy offers a promising molecular intervention for endocrine diseases, including monogenic and multifactorial conditions like diabetes and obesity. This review explores current gene transfer approaches, limitations, and future directions for endocrine disorder treatment.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • Gene therapy is emerging as a potential curative treatment for endocrine disorders.
  • Both monogenic (e.g., GH deficiency) and multifactorial (e.g., diabetes mellitus, obesity, cancer) endocrine diseases are potential targets.
  • Cell and gene therapy combinations show promise for various endocrine conditions.

Purpose of the Study:

  • To review the principles of gene therapy in the context of endocrine diseases.
  • To identify endocrine disorders amenable to gene transfer approaches.
  • To discuss current gene therapy interventions, their limitations, and challenges.

Main Methods:

  • Literature review of gene therapy principles and applications in endocrinology.
  • Analysis of endocrine disorders suitable for gene therapy.
  • Evaluation of existing gene therapy interventions and their outcomes.

Main Results:

  • Gene therapy holds potential for treating a range of endocrine disorders.
  • Specific examples include growth hormone deficiency, diabetes insipidus, diabetes mellitus, obesity, and endocrine tumors.
  • Current interventions face limitations that require further research and development.

Conclusions:

  • Gene therapy presents a novel therapeutic avenue for endocrine diseases.
  • Further research is needed to overcome limitations and optimize gene transfer strategies.
  • Combined cell and gene therapy approaches may offer enhanced treatment options for endocrine disorders.

Related Concept Videos

Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
What is Genetic Engineering?01:34

What is Genetic Engineering?

Genetic engineering is the process of modifying an organism’s DNA to introduce new, desirable traits. Many organisms, from bacteria to plants and animals, have been genetically modified for academic, medical, agricultural, and industrial purposes. While genetic engineering has definite benefits, ethical concerns surround modifying humans and our food supply.Scientists can Deliberately Modify an Organism’s GenomeGenetic engineering is possible because the genetic code—the way information is...